Vera Therapeutics (VERA) Other Working Capital Changes (2020 - 2026)

Vera Therapeutics (VERA) has 5 years of Other Working Capital Changes data on file, last reported at -$182000.0 in Q1 2026.

• Quarterly Other Working Capital Changes rose 53.81% year-over-year to -$182000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (up 41.27% YoY) and the FY2025 annual result came in at -$1.5 million, up 38.39% from the prior year.
• Other Working Capital Changes eased to -$182000.0 in Q1 2026, from -$100000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $5.9 million in Q1 2025 to a low of -$6.0 million in Q2 2025.
• A 5-year average of $71294.1 and a median of -$9000.0 in 2024 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2023 — Other Working Capital Changes dropped 8.63% — and 2025, when it soared 81.1%.
• Tracing VERA's Other Working Capital Changes over 5 years: stood at -$693000.0 in 2022, then advanced by 6.35% to -$649000.0 in 2023, then gained by 18.49% to -$529000.0 in 2024, then soared by 81.1% to -$100000.0 in 2025, then tumbled by 82.0% to -$182000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$182000.0 (Q1 2026), -$100000.0 (Q4 2025), and -$520000.0 (Q3 2025), per Business Quant data.